Author

D. Olszewski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Gomez-Gonzalez· 1 shared A. Petkidis· 1 shared D. Sequeira· 1 shared F. Kuttler· 1 shared G. Turcatti· 1 shared L. P. Murer· 1 shared L. Yang· 1 shared M. Bauer· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Gomez-Gonzalez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Arrayed multicycle drug screens identify broadly acting chemical inhibitors for repurposing against SARS CoV 2

L. P. Murer, R. Volle, V. Andriasyan, N. Meili, L. Yang, D. Sequeira, A. Gomez-Gonzalez, A. Petkidis, D. Olszewski, M. Bauer, M. Suomalainen, F. Kuttler, G. Turcatti, U. F. Greber

The paper screens 5440 compounds to identify chemical inhibitors effective against multiple coronaviruses, including SARS-CoV-2, finding several FDA-approved drugs with potential for repurposing.

bioRxiv · Mar 30, 2021 · PreprintMicrobiology